Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Phenotype of ribonuclease 1 deficiency in mice.

Garnett, Emily R; Lomax, Jo E; Mohammed, Bassem M; Gailani, David; Sheehan, John P; Raines, Ronald T.

RNA ; 25(8): 921-934, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-31053653

2.

Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Tanratana, Pansakorn; Ellery, Paul; Westmark, Pamela; Mast, Alan E; Sheehan, John P.

Arterioscler Thromb Vasc Biol ; 38(1): 266-274, 2018 01.

Artículo en Inglés | MEDLINE | ID: mdl-29097362

3.

Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.

Plautz, William E; Sekhar Pilli, Vijaya Satish; Cooley, Brian C; Chattopadhyay, Rima; Westmark, Pamela R; Getz, Todd; Paul, David; Bergmeier, Wolfgang; Sheehan, John P; Majumder, Rinku.

Arterioscler Thromb Vasc Biol ; 38(4): 816-828, 2018 04.

Artículo en Inglés | MEDLINE | ID: mdl-29419409

4.

Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.

Chanakira, Alice; Westmark, Pamela R; Ong, Irene M; Sheehan, John P.

Gynecol Oncol ; 145(1): 167-175, 2017 04.

Artículo en Inglés | MEDLINE | ID: mdl-28148395

5.

Zebrafish factor 10 and the life aquatic.

Sheehan, John P.

Blood ; 130(5): 563-565, 2017 08 03.

Artículo en Inglés | MEDLINE | ID: mdl-28775159

6.

A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.

Misenheimer, Tina M; Lasarev, Michael R; Kumfer, Kraig T; Sheehan, John P; Schwartz, Bradford S.

Res Pract Thromb Haemost ; 8(1): 102338, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-38433974

7.

Activation of factor XI by products of prothrombin activation.

Matafonov, Anton; Sarilla, Suryakala; Sun, Mao-fu; Sheehan, John P; Serebrov, Vladimir; Verhamme, Ingrid M; Gailani, David.

Blood ; 118(2): 437-45, 2011 Jul 14.

Artículo en Inglés | MEDLINE | ID: mdl-21527525

8.

Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.

Buyue, Yang; Sheehan, John P.

Blood ; 114(14): 3092-100, 2009 Oct 01.

Artículo en Inglés | MEDLINE | ID: mdl-19414859

9.

The regulation of factor IXa by supersulfated low molecular weight heparin.

Misenheimer, Tina M; Sheehan, John P.

Biochemistry ; 49(46): 9997-10005, 2010 Nov 23.

Artículo en Inglés | MEDLINE | ID: mdl-20945941

10.

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.

Buyue, Yang; Whinna, Herbert C; Sheehan, John P.

Blood ; 112(8): 3234-41, 2008 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-18647957

11.

Mapping the zymogen to protease transition in FIXa.

Sheehan, John P.

J Thromb Haemost ; 19(6): 1409-1411, 2021 06.

Artículo en Inglés | MEDLINE | ID: mdl-34047009

12.

New developments in the management of moderate-to-severe hemophilia B.

Nazeef, Moniba; Sheehan, John P.

J Blood Med ; 7: 27-38, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-27099538

13.

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.

Grundy, Scott M; Vega, Gloria Lena; McGovern, Mark E; Tulloch, Brian R; Kendall, David M; Fitz-Patrick, David; Ganda, Om P; Rosenson, Robert S; Buse, John B; Robertson, David D; Sheehan, John P.

Arch Intern Med ; 162(14): 1568-76, 2002 Jul 22.

Artículo en Inglés | MEDLINE | ID: mdl-12123399

14.

Bad medicine: there is a lot wrong with diabetes care in the United States.

Sheehan, John P.

Cult Med Psychiatry ; 34(1): 2-12, 2010 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-20066481

15.

Fasting hyperglycemia: etiology, diagnosis, and treatment.

Sheehan, John P.

Diabetes Technol Ther ; 6(4): 525-33, 2004 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15321011

16.

The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.

Misenheimer, Tina M; Buyue, Yang; Sheehan, John P.

Biochemistry ; 46(26): 7886-95, 2007 Jul 03.

Artículo en Inglés | MEDLINE | ID: mdl-17563121

17.

Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.

Sheehan, John P; Walke, Erik N.

Blood ; 107(10): 3876-82, 2006 May 15.

Artículo en Inglés | MEDLINE | ID: mdl-16672689

18.

The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.

Yuan, Qiu-Ping; Walke, Erik N; Sheehan, John P.

Biochemistry ; 44(9): 3615-25, 2005 Mar 08.

Artículo en Inglés | MEDLINE | ID: mdl-15736971

19.

Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.

Sheehan, John P; Kobbervig, Catherine E; Kirkpatrick, Heidi M.

Biochemistry ; 42(38): 11316-25, 2003 Sep 30.

Artículo en Inglés | MEDLINE | ID: mdl-14503882

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Phenotype of ribonuclease 1 deficiency in mice.

Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.

Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.

Zebrafish factor 10 and the life aquatic.

A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.

Activation of factor XI by products of prothrombin activation.

Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.

The regulation of factor IXa by supersulfated low molecular weight heparin.

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.

Mapping the zymogen to protease transition in FIXa.

New developments in the management of moderate-to-severe hemophilia B.

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.

Bad medicine: there is a lot wrong with diabetes care in the United States.

Fasting hyperglycemia: etiology, diagnosis, and treatment.

The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.

Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.

The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.

Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.